FIELD: pharmaceutical industry.
SUBSTANCE: inventions group relates to a pharmaceutical industry, namely to a composition for the treatment and/or prevention of psoriasis or psoriasis outbreaks and its use. The use of a probiotic composition contains Bifidobacterium animalis subsp. Lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus in a therapeutically effective amount for the treatment and/or prevention of psoriasis and/or psoriasis outbreaks, where B. lactis is a B. lactis CECT 8145, B. longum is a B. Longum ES1 CECT 7347 and/or L, rhamnosus is a L. rhamnosus CECT 8361. Probiotic composition for the treatment and/or prevention of outbreaks of psoriasis and/or psoriasis, contains a therapeutically effective amount of microorganisms Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, where B. lactis is a B. lactis CECT 8145, B. longum is a B. longum ES1 CECT 7347 and/or L. rhamnosus is a L. rhamnosus CECT 8361, wherein the concentration of B. longum ES1 CECT 7347, based on the total concentration of microorganisms present in the composition, is at least 30%.
EFFECT: composition is effective for the treatment and/or prevention of psoriasis or psoriasis outbreaks.
12 cl, 11 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2017 |
|
RU2757453C2 |
USING PROBIOTICS TO ENHANCE MALE FERTILITY | 2015 |
|
RU2724534C2 |
PROBIOTIC STRAINS HAVING THE ABILITY TO ABSORB CHOLESTEROL, METHODS AND USE THEREOF | 2015 |
|
RU2722038C2 |
MAMMAL MILK CELLS, COMPOSITIONS CONTAINING THEM, AND USING THEM FOR TREATING MASTITIS | 2008 |
|
RU2446814C2 |
COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS APPLICATION IN PREVENTION AND /OR TREATMENT OF RESPIRATORY PATHOLOGIES AND/OR INFECTIONS AND IN IMPROVEMENT OF INTESTINE FUNCTION | 2005 |
|
RU2418063C2 |
USE OF PROBIOTIC BACTERIUM LYSATE FOR IMPROVEMENT AND/OR RESTORATION OF BARRIER FUNCTION OF SKIN | 2013 |
|
RU2656152C2 |
RECOVERING, IDENTIFYING AND DESCRIBING STRAINS WITH PROBIOTIC ACTIVITY RECOVERED FROM FAECES OF EXCLUSIVELY BREAST-FED CHILDREN | 2010 |
|
RU2551315C2 |
BACTERIUM LACTOBACILLUS RHAMNOSUS FOR THE TREATMENT OF, FOR EXAMPLE, BACTERIAL VAGINOSIS | 2016 |
|
RU2758109C2 |
COMPOSITION CONTAINING PROBIOTIC BACTERIA CAPABLE OF RESTORING THE BARRIER EFFECT OF THE STOMACH, LOST IN PROCESS OF PHARMACOLOGICAL TREATMENT OF INCREASED ACIDITY OF THE STOMACH | 2012 |
|
RU2685226C2 |
COMPOSITION CONTAINING N-ACETYLCYSTEINE IN COMBINATION WITH PROBIOTIC BACTERIA ABLE TO RESTORE THEIR OWN STOMACH BARRIER EFFECT LOST PHARMA DURING PHARMACOLOGICAL TREATMENT OF GASTRIC HYPERACIDITY | 2012 |
|
RU2617952C2 |
Authors
Dates
2022-03-23—Published
2017-03-21—Filed